1.
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
by Timpson, Nicholas J
The Lancet (British edition), 2005-12-03, Vol.366 (9501), p.1954-1959
2.
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease
by Wiseman, Stewart J
Cerebrovascular diseases (Basel, Switzerland), 2015-09, Vol.40 (3-4), p.157-164
3.
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls
by Ye, Zheng
The Lancet (British edition), 2006, Vol.367 (9511), p.651-658
4.
Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic Stroke
by Welsh, Paul
Cerebrovascular diseases (Basel, Switzerland), 2009-03, Vol.27 (3), p.247-253
5.
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
by Sarwar, Nadeem
The Lancet (British edition), 2012, Vol.379 (9822), p.1205-1213
6.
Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study
by GIMENO, David
European journal of epidemiology, 2007-10-01, Vol.22 (10), p.675-683
7.
Is venous thrombosis a risk factor for arterial thrombosis?
by Lowe, Gordon DO
The Lancet (British edition), 2007, Vol.370 (9601), p.1742-1744
8.
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery
by Lowe, Gordon DO
The Lancet (British edition), 2003-11-08, Vol.362 (9395), p.1582-1582
9.
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
by Lowe, Gordon DO
The Lancet (British edition), 2003, Vol.362 (9383), p.504-505
10.
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66a307 controls
by Ye, Zheng
The Lancet (British edition), 2006-02-25, Vol.367 (9511), p.651
11.
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66a[euro]155 cases and 91a[euro]307 controls
by Ye, Zheng
The Lancet (British edition), 2006-02-25, Vol.367 (9511), p.651
12.
Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3)
by Lewis, Steff C
Journal of neurology, neurosurgery and psychiatry, 2008-04, Vol.79 (4), p.397-400
13.
Oral contraceptives and venous thromboembolism
by Lowe, Gordon DO
The Lancet (British edition), 1997, Vol.349 (9065), p.1623-1623
14.
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-cont...
by Ledermann, Jonathan A, Prof
The lancet oncology, 2016, Vol.17 (11), p.1579-1589
15.
Practical challenges to the clinical implementation of saliva for SARS-CoV-2 detection
by Matic, Nancy
European journal of clinical microbiology & infectious diseases, 2020-11-25, Vol.40 (2), p.447-450
16.
An Analysis of Prospective Risk Factors for Aortic Stiffness in Men: 20-Year Follow-Up From the Caerphilly Prospective Study
by McEniery, Carmel M
Hypertension (Dallas, Tex. 1979), 2010-07, Vol.56 (1), p.36-43
17.
Common Variants of Large Effect in F12, KNG1, and HRG Are Associated with Activated Partial Thromboplastin Time
by Houlihan, Lorna M
American journal of human genetics, 2010, Vol.86 (4), p.626-631
18.
Cyclin-dependent kinase complexes in developing maize endosperm: evidence for differential expression and functional specialization
by Dante, Ricardo A
Planta, 2014-02-01, Vol.239 (2), p.493-509
19.
Symptoms associated with influenza vaccination and experimental human pneumococcal colonisation of the nasopharynx
by Hales, Caz
Vaccine, 2020-02-28, Vol.38 (10), p.2298-2306
20.
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3])...
by Sandercock, Peter
The Lancet (British edition), 2012, Vol.379 (9834), p.2352-2363
